Jensen JU et al. - The objective was to address whether daily Procalcitonin measurements and immediate diagnostic and therapeutic response on day-to-day changes in procalcitonin can reduce the mortality of critically ill patients. Results will answer the question: Can the survival of critically ill patients be improved by actively using biomarker procalcitonin in the treatment of infections.